DOLORES REMEDIOS
SERRANO LÓPEZ
Profesora titular de universidad
MARÍA DE LA PALOMA
BALLESTEROS PAPANTONAKIS
Profesora titular de universidad
MARÍA DE LA PALOMA BALLESTEROS PAPANTONAKIS-rekin lankidetzan egindako argitalpenak (20)
2023
-
Application of Accelerated Predictive Stability Studies in Extemporaneously Compounded Formulations of Chlorhexidine to Assess the Shelf Life
Molecules, Vol. 28, Núm. 23
-
Can amphotericin B and itraconazole be co-delivered orally? Tailoring oral fixed-dose combination coated granules for systemic mycoses
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 183, pp. 74-91
-
Co-Delivery of a High Dose of Amphotericin B and Itraconazole by Means of a Dry Powder Inhaler Formulation for the Treatment of Severe Fungal Pulmonary Infections
Pharmaceutics, Vol. 15, Núm. 11
-
Engineering of 3D printed personalized polypills for the treatment of the metabolic syndrome
International Journal of Pharmaceutics, Vol. 642
-
Guiding Clinical Prescription of Topical Extemporaneous Formulations of Sodium Cromoglycate Based on Pharmaceutical Performance
Pharmaceutics, Vol. 15, Núm. 6
-
Targeting lung macrophages for fungal and parasitic pulmonary infections with innovative amphotericin B dry powder inhalers
International journal of pharmaceutics, Vol. 635, pp. 122788
2022
-
Drug Stability: ICH versus Accelerated Predictive Stability Studies
Pharmaceutics, Vol. 14, Núm. 11
-
Self-assembling, supramolecular chemistry and pharmacology of amphotericin B: Poly-aggregates, oligomers and monomers
Journal of Controlled Release, Vol. 341, pp. 716-732
2020
-
Oral Fixed-Dose Combination Pharmaceutical Products: Industrial Manufacturing Versus Personalized 3D Printing
Pharmaceutical Research, Vol. 37, Núm. 7
-
Personalised 3d printed medicines: Optimising material properties for successful passive diffusion loading of filaments for fused deposition modelling of solid dosage forms
Pharmaceutics, Vol. 12, Núm. 4
-
Transferosomes as nanocarriers for drugs across the skin: Quality by design from lab to industrial scale
International Journal of Pharmaceutics, Vol. 573
-
Ultradeformable Lipid Vesicles Localize Amphotericin B in the Dermis for the Treatment of Infectious Skin Diseases
ACS Infectious Diseases, Vol. 6, Núm. 10, pp. 2647-2660
2019
-
Market demands in 3D printing pharmaceuticals products
3D Printing Technology in Nanomedicine (Elsevier), pp. 165-183
2017
-
Analgesic and anti-inflammatory controlled-released injectable microemulsion: Pseudo-ternary phase diagrams, in vitro, ex vivo and in vivo evaluation
European Journal of Pharmaceutical Sciences, Vol. 101, pp. 220-227
-
Engineering oral and parenteral amorphous amphotericin B formulations against experimental Trypanosoma cruzi infections
Molecular Pharmaceutics, Vol. 14, Núm. 4, pp. 1095-1106
-
Nebulised antibiotherapy: Conventional versus nanotechnology-based approaches, is targeting at a nano scale a difficult subject?
Annals of Translational Medicine, Vol. 5, Núm. 22
-
Unmet clinical needs in the treatment of systemic fungal infections: The role of amphotericin B and drug targeting
International Journal of Pharmaceutics
2015
-
Oral particle uptake and organ targeting drives the activity of amphotericin B nanoparticles
Molecular Pharmaceutics, Vol. 12, Núm. 2, pp. 420-431
2013
-
Hemolytic and pharmacokinetic studies of liposomal and particulate amphotericin B formulations
International Journal of Pharmaceutics, Vol. 447, Núm. 1-2, pp. 38-46
2012
-
A novel formulation of solubilised amphotericin B designed for ophthalmic use
International Journal of Pharmaceutics, Vol. 437, Núm. 1-2, pp. 80-82